跳至主要内容
临床试验/ISRCTN58496168
ISRCTN58496168已完成不适用

Aspirin and/or low-molecular weight heparin for women with unexplained recurrent miscarriages and/or intra-uterine foetal death

Academic Medical Centre (AMC) (Netherlands)0 个研究点目标入组 300 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Women with at least two unexplained miscarriages and/or intra-uterine foetal deaths

排除标准

  • 1. Previous thromboembolism
  • 2. Antiphospholipid syndrome (APLS)
  • 3. Uterine abnormalities
  • 4. Patients? or their partners? abnormal karyotype
  • 5. Indication for anticoagulant treatment during pregnancy (for instance prosthetic heart valves)
  • 6. Metabolic and toxic factors (diabetes mellitus, radiation exposure)
  • 7. Known erythrocyte antibody anti-P syndrome
  • 8. Pregnancy losses due to documented foetal malformation or the result of an infectious complication
  • 9. Known allergy to at least three different low-molecular-weight heparin (LMWH) preparations
  • 10. Previous inclusion in the ALIFE trial (for another pregnancy)

研究者

发起方
Academic Medical Centre (AMC) (Netherlands)

相似试验